Nielsen HM - Search Results

1

Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression.

Baker C, Nielsen HM, Minthon L, Wright HT, Chappell S, Okyere J, May S, Morgan K, Kalsheker N, Janciauskiene SM. Baker C, et al. Among authors: nielsen hm. Neurobiol Aging. 2007 Jan;28(1):51-61. doi: 10.1016/j.neurobiolaging.2005.10.017. Epub 2005 Dec 20. Neurobiol Aging. 2007. PMID: 16364502

2

Binding and uptake of A beta1-42 by primary human astrocytes in vitro.

Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S. Nielsen HM, et al. Glia. 2009 Jul;57(9):978-88. doi: 10.1002/glia.20822. Glia. 2009. PMID: 19062178

3

Soluble adhesion molecules and angiotensin-converting enzyme in dementia.

Nielsen HM, Londos E, Minthon L, Janciauskiene SM. Nielsen HM, et al. Neurobiol Dis. 2007 Apr;26(1):27-35. doi: 10.1016/j.nbd.2006.11.011. Epub 2007 Jan 31. Neurobiol Dis. 2007. PMID: 17270454

4

C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.

Trouw LA, Nielsen HM, Minthon L, Londos E, Landberg G, Veerhuis R, Janciauskiene S, Blom AM. Trouw LA, et al. Among authors: nielsen hm. Mol Immunol. 2008 Aug;45(13):3649-60. doi: 10.1016/j.molimm.2008.04.025. Epub 2008 Jun 16. Mol Immunol. 2008. PMID: 18556068

5

NG2 cells, a new trail for Alzheimer's disease mechanisms?

Nielsen HM, Ek D, Avdic U, Orbjörn C, Hansson O; Netherlands Brain Bank; Veerhuis R, Rozemuller AJ, Brun A, Minthon L, Wennström M. Nielsen HM, et al. Acta Neuropathol Commun. 2013 May 9;1(1):7. doi: 10.1186/2051-5960-1-7. Acta Neuropathol Commun. 2013. PMID: 24252600 Free PMC article.

6

Involvement of matrix metalloproteinase-9 in amyloid-β 1-42-induced shedding of the pericyte proteoglycan NG2.

Schultz N, Nielsen HM, Minthon L, Wennström M. Schultz N, et al. Among authors: nielsen hm. J Neuropathol Exp Neurol. 2014 Jul;73(7):684-92. doi: 10.1097/NEN.0000000000000084. J Neuropathol Exp Neurol. 2014. PMID: 24918635 Free PMC article.

7

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.

Nielsen HM, Minthon L, Londos E, Blennow K, Miranda E, Perez J, Crowther DC, Lomas DA, Janciauskiene SM. Nielsen HM, et al. Neurology. 2007 Oct 16;69(16):1569-79. doi: 10.1212/01.wnl.0000271077.82508.a0. Epub 2007 Aug 29. Neurology. 2007. PMID: 17761554

8

CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease.

Westin K, Buchhave P, Nielsen H, Minthon L, Janciauskiene S, Hansson O. Westin K, et al. PLoS One. 2012;7(1):e30525. doi: 10.1371/journal.pone.0030525. Epub 2012 Jan 30. PLoS One. 2012. PMID: 22303443 Free PMC article.

9

Altered CSF orexin and α-synuclein levels in dementia patients.

Wennström M, Londos E, Minthon L, Nielsen HM. Wennström M, et al. Among authors: nielsen hm. J Alzheimers Dis. 2012;29(1):125-32. doi: 10.3233/JAD-2012-111655. J Alzheimers Dis. 2012. PMID: 22207004

10

Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies.

Nielsen HM, Hall S, Surova Y, Nägga K, Nilsson C, Londos E, Minthon L, Hansson O, Wennström M. Nielsen HM, et al. J Alzheimers Dis. 2014;40(2):343-50. doi: 10.3233/JAD-132246. J Alzheimers Dis. 2014. PMID: 24448788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters